Kim L. O'Neill
Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.
O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a full professor of microbiology at Brigham Young University. In 1998 research by O'Neill suggested a link between caffine and the formation of some cancers.[1] O'Neill has served as associate director of BYU's cancer research center.
O'Neill is also a convert to The Church of Jesus Christ of Latter-day Saints, having joined the church in Ireland.
Sources
- Short listing of O'Neill's credentials
- BYU bio
- Patent list for O'Neill
- Article by O'Neill on his discoveries potential
- ↑ Edward L. Carter, "BYU scientist finds caffeine may keep cancer cells alive", Deseret News, Jan. 22, 1998
This article is issued from Wikipedia - version of the 8/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.